Allotment of 140663 shares of face value of Rs.5 at an exercise price of Rs.45 each pursuant to exercise of options by eligible employees under ESOP Scheme
BATLIBOI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Batliboi Ltd announced its unaudited Q3 FY26 (quarter and nine months ended Dec 31, 2025) results along with allotment of 1,40,663 shares under its ESOP scheme at an exercise price of Rs. 45 each (face value Rs. 5), marginally raising paid-up equity capital to Rs. 23.57 crore (4.71 crore shares). Standalone Q3 revenue rose ~10% YoY to Rs. 7,175 lakhs but the company swung to a net loss of Rs. 797 lakhs after booking a one-time exceptional expense of Rs. 749 lakhs. Standalone loss before exceptional item widened to Rs. 326 lakhs in Q3 vs Rs. 154 lakhs a year ago, and for 9M FY26 the company reported a standalone loss of Rs. 723 lakhs vs a profit of Rs. 223 lakhs last year. Consolidated Q3 revenue grew ~30% YoY to Rs. 12,432 lakhs with operating profit of Rs. 480 lakhs before exceptional item, but Q3 consolidated PAT turned negative at Rs. 183 lakhs on the same one-time charge. Comparatives have been restated for the amalgamation of Batliboi Environmental Engineering Ltd, and a new 51% subsidiary (Bioconserve Renewables Envirotech) was incorporated in April 2025.
Standalone profitability is weakening — operating losses widened even before the exceptional Labour Codes charge — which is a red flag for shareholders despite consolidated revenue looking healthy on a quarterly basis. The exceptional hit and continued losses at standalone level may weigh on the stock in the near term, while the Surat land divestment (still pending a buyer) and the small ESOP dilution (~0.3%) are secondary concerns.